Blister-free Syringe Vaccine Market is projected to reach US$ 7412.1 million by 2029 with CAGR of 7.2%
Market Overview The Global Blister-free Syringe Vaccine Market was valued at US$ 4575.6 million in 2022 and is projected to reach US$ 7412.1 million by 2029, at a CAGR of 7.2% during the forecast period. The Blister-free Syringe Vaccine Market has witnessed significant growth in recent years due to the increasing demand for safe and effective vaccination methods. This market encompasses the production, distribution, and administration of vaccines using pre-filled syringes that do not require blister packaging. Blister-free syringe vaccines offer numerous advantages over traditional vial-based vaccines, including improved safety, reduced medication errors, and enhanced convenience for healthcare professionals and…
- Date: March 15, 2024
- Author: Timmy Thomas
- Category: PharmiWeb